A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain

BACKGROUND: Chronic cyclic pelvic pain (CCPP) affects women’s quality of life and pituitary downregulation is often used for symptomatic relief. However, prolonged suppression of ovarian function is associated with menopausal side effects and can lead to osteoporosis. Currently, the use of gonadotro...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshehre, Sallwa M., Duffy, Sheila, Jones, Georgina, Ledger, William L., Metwally, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155249/
https://www.ncbi.nlm.nih.gov/pubmed/32290838
http://dx.doi.org/10.1186/s12958-020-00586-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155249/
https://www.ncbi.nlm.nih.gov/pubmed/32290838
http://dx.doi.org/10.1186/s12958-020-00586-z

Ejemplares similares